Trending News

Blog Post


Pfizer PFE earnings Q1 2021 

A girl holds a small bottle labeled with a “Coronavirus COVID-19 Vaccine” sticker and a medical syringe in entrance of displayed Pfizer emblem on this illustration taken, October 30, 2020.

Dado Ruvic | Reuters

Pfizer on Tuesday reported $3.5 billion in first-quarter gross sales of its Covid-19 vaccine with German drugmaker BioNTech.

In releasing its first-quarter monetary outcomes, the corporate additionally reported earnings and income that beat Wall Avenue’s expectations.

Here is how Pfizer did in contrast with what Wall Avenue anticipated, based on common estimates compiled by Refinitiv:

  • Adjusted EPS: 93 cents per share vs 77 cents anticipated
  • Income: $14.58 billion vs. $13.51 billion anticipated

This can be a growing story. Please test again for updates.

Supply hyperlink

Related posts

Leave a Reply

Required fields are marked *